• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活化蛋白C通过抑制细胞因子产生来预防脂多糖诱导的肺血管损伤。

Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production.

作者信息

Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K

机构信息

Department of Medicine, Kumamoto University Medical School, Japan.

出版信息

Am J Physiol. 1997 Feb;272(2 Pt 1):L197-202. doi: 10.1152/ajplung.1997.272.2.L197.

DOI:10.1152/ajplung.1997.272.2.L197
PMID:9124369
Abstract

We investigated the effect of activated protein C (APC) on pulmonary vascular injury and the increase in tumor necrosis factor (TNF) levels in lipopolysaccharide (LPS)-treated rats to determine whether APC reduces LPS-induced endothelial damage by inhibiting cytokine production. Intravenously administered LPS (5 mg/kg) induced pulmonary vascular injury, as indicated by an increase in the lung wet-to-dry weight ratio. LPS-induced pulmonary vascular injury was prevented by APC but not by active site-blocked factor Xa [dansyl glutamyl-glycyl-arginyl chloromethyl detone-treated activated factor X (DEGR-Xa)], a selective inhibitor of thrombin generation, or inactivated APC [diisopropyl fluorophosphate-treated APC (DIP-APC)]. APC, but not DEGR-Xa or DIP-APC, significantly inhibited the LPS-induced increase in the plasma level of TNF. APC significantly inhibited the production of TNF by LPS-stimulated monocytes in a dose-dependent fashion in vitro, but DIP-APC did not. APC did not inhibit the functions of activated neutrophils in vitro. These findings suggest that APC prevented LPS-induced pulmonary vascular injury by inhibiting TNF production by monocytes and not via its anticoagulant activity. The serine protease activity of APC appears to be essential for inhibition of TNF production.

摘要

我们研究了活化蛋白C(APC)对脂多糖(LPS)处理的大鼠肺血管损伤及肿瘤坏死因子(TNF)水平升高的影响,以确定APC是否通过抑制细胞因子产生来减轻LPS诱导的内皮损伤。静脉注射LPS(5 mg/kg)可诱导肺血管损伤,表现为肺湿重与干重比值增加。APC可预防LPS诱导的肺血管损伤,但凝血酶生成的选择性抑制剂、活性位点被阻断的因子Xa [丹磺酰谷氨酰-甘氨酰-精氨酰氯甲基酮处理的活化因子X(DEGR-Xa)]或灭活的APC [二异丙基氟磷酸处理的APC(DIP-APC)]则不能。APC可显著抑制LPS诱导的血浆TNF水平升高,但DEGR-Xa或DIP-APC则不能。在体外,APC可剂量依赖性地显著抑制LPS刺激的单核细胞产生TNF,但DIP-APC则不能。APC在体外不抑制活化中性粒细胞的功能。这些发现表明,APC通过抑制单核细胞产生TNF而非通过其抗凝活性来预防LPS诱导的肺血管损伤。APC的丝氨酸蛋白酶活性似乎对抑制TNF产生至关重要。

相似文献

1
Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production.活化蛋白C通过抑制细胞因子产生来预防脂多糖诱导的肺血管损伤。
Am J Physiol. 1997 Feb;272(2 Pt 1):L197-202. doi: 10.1152/ajplung.1997.272.2.L197.
2
Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats.活化蛋白C通过抑制大鼠体内活化的白细胞来减轻内毒素诱导的肺血管损伤。
Blood. 1996 Jan 15;87(2):642-7.
3
Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation.活化蛋白C通过抑制白细胞活化减轻大鼠缺血/再灌注诱导的肾损伤。
Blood. 2000 Jun 15;95(12):3781-7.
4
Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation.活化蛋白C通过抑制中性粒细胞活化减轻大鼠缺血/再灌注诱导的脊髓损伤。
Ann Surg. 2000 Aug;232(2):272-80. doi: 10.1097/00000658-200008000-00018.
5
Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide.活化蛋白C通过抑制一氧化氮的过量产生来预防大鼠内毒素诱导的低血压。
Circulation. 2001 Sep 4;104(10):1171-5. doi: 10.1161/hc3501.093799.
6
Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in rats.内毒素诱导的肺血管损伤在大鼠中主要由活化的中性粒细胞介导。
Thromb Res. 1995 Apr 15;78(2):117-25. doi: 10.1016/0049-3848(95)00040-2.
7
Recombinant human soluble thrombomodulin reduces endotoxin-induced pulmonary vascular injury via protein C activation in rats.重组人可溶性血栓调节蛋白通过激活蛋白C减轻大鼠内毒素诱导的肺血管损伤。
Thromb Haemost. 1995 Nov;74(5):1265-70.
8
Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation.重组组织因子途径抑制剂通过抑制白细胞活化减轻脂多糖诱导的肺血管损伤。
Am J Respir Crit Care Med. 2000 Nov;162(5):1752-9. doi: 10.1164/ajrccm.162.5.9911018.
9
Activated protein C reduces the severity of compression-induced spinal cord injury in rats by inhibiting activation of leukocytes.活化蛋白C通过抑制白细胞活化来减轻大鼠压迫性脊髓损伤的严重程度。
J Neurosci. 1998 Feb 15;18(4):1393-8. doi: 10.1523/JNEUROSCI.18-04-01393.1998.
10
Effect of nafamostat mesilate on pulmonary vascular injury induced by lipopolysaccharide in rats.甲磺酸萘莫司他对脂多糖诱导的大鼠肺血管损伤的影响。
Am J Respir Crit Care Med. 1997 Feb;155(2):711-8. doi: 10.1164/ajrccm.155.2.9032217.

引用本文的文献

1
Old drug, new Trick? The rationale for the treatment of COVID-19 with activated protein C.老药新用?用活化蛋白 C 治疗 COVID-19 的基本原理。
Med Hypotheses. 2021 Apr;149:110537. doi: 10.1016/j.mehy.2021.110537. Epub 2021 Feb 16.
2
Stabilizing Cellular Barriers: Raising the Shields Against COVID-19.稳定细胞屏障:对抗 COVID-19 的盾牌。
Front Endocrinol (Lausanne). 2020 Sep 30;11:583006. doi: 10.3389/fendo.2020.583006. eCollection 2020.
3
Coagulopathies and inflammatory diseases: '…glimpse of a Snark'.凝血功能障碍与炎症性疾病:“……瞥见一条 Snark”。
Curr Opin Immunol. 2018 Dec;55:44-53. doi: 10.1016/j.coi.2018.09.005. Epub 2018 Sep 27.
4
Activated protein C inhibits lung injury induced by LPS via downregulating MAPK signaling.活化蛋白C通过下调丝裂原活化蛋白激酶(MAPK)信号传导来抑制脂多糖(LPS)诱导的肺损伤。
Exp Ther Med. 2018 Aug;16(2):931-936. doi: 10.3892/etm.2018.6228. Epub 2018 May 29.
5
Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality.活化蛋白C对伴有急性呼吸窘迫综合征的脓毒症患者肺毛细血管内皮功能无影响:内皮功能障碍与死亡率的关系
Infect Dis Ther. 2018 Mar;7(Suppl 1):15-25. doi: 10.1007/s40121-018-0192-3. Epub 2018 Mar 16.
6
Activated protein C binds directly to Tie2: possible beneficial effects on endothelial barrier function.活化蛋白C直接与Tie2结合:对内皮屏障功能可能产生有益影响。
Cell Mol Life Sci. 2017 May;74(10):1895-1906. doi: 10.1007/s00018-016-2440-6. Epub 2016 Dec 22.
7
Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.血栓调节蛋白对特发性肺纤维化和非特异性间质性肺炎急性加重期的疗效:一项非随机前瞻性研究。
Drug Des Devel Ther. 2015 Oct 23;9:5755-62. doi: 10.2147/DDDT.S90739. eCollection 2015.
8
Combination therapy with sivelestat and recombinant human soluble thrombomodulin for ARDS and DIC patients.西维来司他与重组人可溶性血栓调节蛋白联合治疗急性呼吸窘迫综合征和弥散性血管内凝血患者。
Drug Des Devel Ther. 2014 Sep 2;8:1211-9. doi: 10.2147/DDDT.S68030. eCollection 2014.
9
Regulation of endothelial cell inflammation and lung polymorphonuclear lymphocyte infiltration by transglutaminase 2.转谷氨酰胺酶2对内皮细胞炎症和肺多形核淋巴细胞浸润的调节作用
Shock. 2014 Dec;42(6):562-9. doi: 10.1097/SHK.0000000000000242.
10
Targeting the host hemostatic system function in bacterial infection for antimicrobial therapies.针对细菌感染中宿主止血系统功能的抗菌治疗策略。
J Thromb Thrombolysis. 2014 Jan;37(1):66-73. doi: 10.1007/s11239-013-0994-9.